![Nuvectis Pharma, Inc. logo](/logos/NVCT.webp)
Nuvectis Pharma, Inc.
NASDAQ:NVCT
Overview | Financials
Company Name | Nuvectis Pharma, Inc. |
Symbol | NVCT |
Currency | USD |
Price | 6.18 |
Market Cap | 115,273,606 |
Dividend Yield | 0% |
52-week-range | 5.85 - 14.98 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Ron Bentsur M.B.A. |
Website | https://www.nuvectis.com |
An error occurred while fetching data.
About Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD